{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:41:46Z","timestamp":1786117306279,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014717","name":"Youth Science Fund Project","doi-asserted-by":"publisher","award":["82500852"],"award-info":[{"award-number":["82500852"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2019-I2M-5-046"],"award-info":[{"award-number":["2019-I2M-5-046"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC2511000"],"award-info":[{"award-number":["2024YFC2511000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ekir.2026.106653","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:45:30Z","timestamp":1781023530000},"page":"106653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Time-Updated Hematuria and Kidney Disease Progression in IgAN"],"prefix":"10.1016","volume":"11","author":[{"given":"Chen","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Lei","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Yin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Cheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Fang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2026.106653_bib1","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106653_bib2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2215\/CJN.0000000000000135","article-title":"Long-term outcomes in IgA nephropathy","volume":"18","author":"Pitcher","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106653_bib3","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/ndt\/gfae252","article-title":"Long-term outcomes of IgA nephropathy in China","volume":"40","author":"Shen","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106653_bib4","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1093\/ndt\/gfad146","article-title":"IgA nephropathy in adults-treatment standard","volume":"38","author":"Gleeson","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106653_bib5","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1681\/ASN.2017060639","article-title":"Persistent microscopic hematuria as a risk factor for progression of IgA nephropathy: new floodlight on a nearly forgotten biomarker","volume":"28","author":"Coppo","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106653_bib6","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.3390\/jcm11226785","article-title":"Time-averaged hematuria as a prognostic indicator of renal outcome in patients with IgA nephropathy","volume":"11","author":"Weng","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ekir.2026.106653_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.ajkd.2019.11.008","article-title":"Persistent hematuria and kidney disease progression in IgA nephropathy: a cohort study","volume":"76","author":"Yu","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.106653_bib8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000529650","article-title":"Clinical significance of persistent hematuria degrees in primary IgA nephropathy: a propensity score-matched analysis of a 10-year follow-up cohort","volume":"54","author":"Huang","year":"2023","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2026.106653_bib9","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/ndt\/gfz267","article-title":"The association of microhematuria with mesangial hypercellularity, endocapillary hypercellularity, crescent score and renal outcomes in immunoglobulin A nephropathy","volume":"36","author":"Bobart","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106653_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1159\/000525001","article-title":"Long-term outcomes of patients with IgA nephropathy categorized by the international IgAN risk prediction tool and by the degree of hematuria at diagnosis","volume":"146","author":"Ebbestad","year":"2022","journal-title":"Nephron"},{"key":"10.1016\/j.ekir.2026.106653_bib11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/ckj\/sfab244","article-title":"Corticosteroids and mycophenolic acid analogues in immunoglobulin A nephropathy with progressive decline in kidney function","volume":"15","author":"Huerta","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2026.106653_bib12","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1681\/ASN.2017010108","article-title":"Remission of hematuria improves renal survival in IgA nephropathy","volume":"28","author":"Sevillano","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106653_bib13","article-title":"Retrospective analysis of clinical outcomes in patients with immunoglobulin A nephropathy and persistent hematuria following renin-angiotensin system blockade","volume":"26","author":"Chen","year":"2020","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ekir.2026.106653_bib14","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.kint.2025.04.003","article-title":"Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)","volume":"108","author":"Floege","year":"2025","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"10.1016\/j.ekir.2026.106653_bib15","doi-asserted-by":"crossref","first-page":"ii19","DOI":"10.1093\/ckj\/sfad232","article-title":"Microscopic hematuria as a risk factor for IgAN progression: considering this biomarker in selecting and monitoring patients","volume":"16","author":"Zand","year":"2023","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2026.106653_bib16","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.3390\/ijms20092205","article-title":"Glomerular hematuria: cause or consequence of renal inflammation?","volume":"20","author":"Moreno","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ekir.2026.106653_bib17","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.2215\/CJN.00650117","article-title":"Statistical methods for modeling time-updated exposures in cohort studies of chronic kidney disease","volume":"12","author":"Xie","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106653_bib18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.clinbiochem.2018.04.008","article-title":"The efficient workflow to decrease the manual microscopic examination of urine sediment using on-screen review of images","volume":"56","author":"Cho","year":"2018","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ekir.2026.106653_bib19","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10157-014-1001-2","article-title":"Japanese guidelines of the management of hematuria 2013","volume":"18","author":"Horie","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.ekir.2026.106653_bib20","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ekir.2026.106653_bib21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nrneph.2012.248","article-title":"Assessing risk in chronic kidney disease: a methodological review","volume":"9","author":"Grams","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2026.106653_bib22","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"key":"10.1016\/j.ekir.2026.106653_bib23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1053\/j.ajkd.2023.12.016","article-title":"Time-varying proteinuria and progression of IgA nephropathy: a cohort study","volume":"84","author":"Tang","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.106653_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.semnephrol.2004.01.001","article-title":"Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome","volume":"24","author":"D\u2019Amico","year":"2004","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.ekir.2026.106653_bib25","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1093\/ndt\/gfp273","article-title":"A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study","volume":"24","author":"Goto","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106653_bib26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.15171\/jnp.2016.12","article-title":"Effect of hematuria on the outcome of immunoglobulin A nephropathy with proteinuria","volume":"5","author":"Iwasaki","year":"2016","journal-title":"J Nephropathol"},{"key":"10.1016\/j.ekir.2026.106653_bib27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00281-021-00883-8","article-title":"IgA glycosylation and immune complex formation in IgAN","volume":"43","author":"Suzuki","year":"2021","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.ekir.2026.106653_bib28","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/path.5011","article-title":"Podocytes are new cellular targets of haemoglobin-mediated renal damage","volume":"244","author":"Rubio-Navarro","year":"2018","journal-title":"J Pathol"},{"key":"10.1016\/j.ekir.2026.106653_bib29","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2215\/CJN.0000000952","article-title":"The association between low-grade proteinuria and adverse kidney outcomes in IgA nephropathy: a systematic review and meta-analysis","volume":"21","author":"Yamaguchi","year":"2026","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106653_bib30","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1681\/ASN.2006040377","article-title":"How does proteinuria cause progressive renal damage?","volume":"17","author":"Abbate","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106653_bib31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1681\/ASN.0000000000000465","article-title":"Lactobacillus casei cell wall extract and production of galactose-deficient IgA1 in a humanized IGHA1 mouse model","volume":"36","author":"Li","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106653_bib32","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/ki.1985.76","article-title":"Spontaneous glomerular IgA deposition in ddY mice: an animal model of IgA nephritis","volume":"27","author":"Imai","year":"1985","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106653_bib33","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1681\/ASN.2015080856","article-title":"IgA1 protease treatment reverses mesangial deposits and hematuria in a model of IgA nephropathy","volume":"27","author":"Lechner","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106653_bib34","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa2410316","article-title":"Alternative complement pathway inhibition with iptacopan in IgA nephropathy","volume":"392","author":"Perkovic","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106653_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ekir.2025.10.017","article-title":"Iptacopan in patients with IgA nephropathy from East Asia","volume":"11","author":"Zhang","year":"2026","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2026.106653_bib36","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa2512133","article-title":"Sibeprenlimab in IgA nephropathy - interim analysis of a Phase 3 trial","volume":"394","author":"Perkovic","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106653_bib37","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJMoa2510198","article-title":"A Phase 3 trial of atacicept in patients with IgA nephropathy","volume":"394","author":"Lafayette","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106653_bib38","first-page":"562","article-title":"Sysmex UF-5000 automatic urine sediment analyzer can improve the accuracy of epithelial cell detection","volume":"51","author":"Chen","year":"2021","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.ekir.2026.106653_bib39","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3343\/alm.2022.42.2.160","article-title":"Diagnostic characteristics of urinary red blood cell distribution incorporated in UF-5000 for differentiation of glomerular and non-glomerular hematuria","volume":"42","author":"Cho","year":"2022","journal-title":"Ann Lab Med"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926028858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926028858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:44:00Z","timestamp":1786023840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024926028858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2468024926028858"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2026.106653","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time-Updated Hematuria and Kidney Disease Progression in IgAN","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2026.106653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}],"article-number":"106653"}}